Screener
AbCellera Biologics Inc. ABCL Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$55.43M-59.6% | -$43.17M+5.4% | -$8.95M+73.9% | -$57.12M-11.8% | -$34.73M+6.0% | ||
| $6.1M+32.6% | $5.92M+34.2% | $5.18M+147% | $4.3M+13.2% | $4.6M+35.3% | ||
| $12.29M-13.5% | $12.01M-18.8% | $12.9M-15.3% | $13.9M-19.0% | $14.21M-20.1% | ||
| —— | -$33.52M-190% | -$34.74M-334% | -$52.59M-82.1% | -$32.4M-8.1% | ||
| $2.13M-84.0% | $3.83M-64.0% | $9.84M-37.0% | $8.93M-51.8% | $13.37M-33.5% | ||
| —— | -$25.08M-416% | $75.14M+110% | $36.49M+887% | -$31.81M-161% | ||
| $6.39M— | $7.19M+20.5% | $4.12M-0.7% | $7.37M+134% | —— | ||
| —— | -$51.45M-1,849% | —— | -$9.28M+57.2% | -$66.83M-370% |
FAQ
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
